None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - men and women over 19 years of age - a patient scheduled for thoracoscopic lung resection
Exclusion criteria
Exclusion criteria: - Women who are pregnant or lactating, women who plan to become pregnant during clinical trials - a patient on anti-inflammatory medication for chronic inflammatory disease - an active alcoholic patient - Patients with a history of hypersensitivity or history of nonsteroidal anti-inflammatory drugs - a patient with a severe liver disorder - Patients with gastrointestinal ulcers, gastrointestinal bleeding, or a history of it - a patient with bronchial asthma or a history of it - Other conditions/abnormalities: uncontrolled or uncontrolled medical endocrine or uncontrolled hematologic abnormalities among clinically significant cardiovascular, neurological, psychiatric, kidney, liver, immunity, medication carefully administered (including those in this condition; coronary artery disease, acute myocardial infarction, deep vein thrombosis, hypertension, convulsive disorder, thyrotoxicosis, hypokalemia, etc.) - a weight of less than 50 kg * Significance is defined as any disease that will affect the efficacy or safety analysis if, as judged by the clinical trial physician, the safety of the subject is put at risk by participation or if the condition/condition deteriorates during the clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum pain score within 48 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs and blood test results;Pain Score (NRS);opioid dugs dosage;a combination of drugs;adverse event(AE) | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center